Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Relay Therapeutics, Inc. (NASDAQ: RLAY)
RLAY Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
73.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
55.80%
RLAY Stock Analysis
RLAY
PE Ratio:
RLAY
PEG Ratio:
Not Available
RLAY
Forward EPS Growth (12 month):
0.00%
RLAY
PS Ratio:
274.5
RLAY
PSG Ratio:
1.7
RLAY
Forward Revenue Growth (12 month):
160.30%
RLAY Articles
No data was found